Breast Cancer Survival Rates - Dare To Know Your Chances

s technological and laboratory advances made ​​in the field of oncology, breast cancer survival of women have improved in the last two decades, but still, more studies should be done.

A recent report on breast cancer suggest that there is a significant advancement in breast cancer survival rate among patients who were treated with the latest therapies.

Here's breast cancer survival rate in patients who were diagnosed with cancer within a certain period of time, shows a significant increase in survival rates between the old and new patients:
• 10% of patients from 1974 to 1979
• 14% of patients from 1980 to 1984
• 22% of patients from 1985 to 1989
• 29% of patients from 1990 to 1994
• 44% of patients from 1995 to 2000

more recent group of patients, better prognostic variables and long žive.Glavni reason behind these great changes and advances in drugs and tretmana.Najpovoljnija variables are:
• The smaller size of the tumor
• lower levels of disease status
• fewer lymph nodes involved
• disease free interval longer
• Tumors with positive estrogen receptors (which are tumors that use estrogen to grow).
• Tumors that do not involve major organs

estimated the risk reduction started 1% to 2% annually, but is constantly increasing, although the change is not statistically very significant. This statistic is consistent with data Seet (database of results found by the National Cancer Institute surveillance Epidemilogy and final results)

Current statistics show breast cancer?
In 2004, approximately 217,440 new cases of breast cancer diagnosed in the United States, and 40.580 women are expected to die of metastases, in accordance with the report of the American Cancer Society.

However, improvements in radiographic techniques and more precise imaging techniques can alter the distribution phase. Small metastases that could be detected with modern imaging techniques 90 could be passed without notice in the 70s.

What could be responsible for increasing the survival rate of breast cancer?
Marked increase is the result of more research period and the number of drugs to treat cancer. One of the largest increases occurred in the 90s with drugs such as taxanes, vinorelbine, capecitabine, Herceptin, aromatase inhibitors and pamidronate.

Despite the advances, improvements in survival rates of patients, particularly in the metastatic phase, were difficult to determine.

breast cancer mortality is declining, however. From 1995 to 1999, breast cancer rates have declined by about 3.2% per year. But it remains unclear whether the decline most of the patients diagnosed with early stage disease or improvements in treatment.